Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study

[1]  V. Beral,et al.  Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci. , 2010, JAMA.

[2]  T. Meitinger,et al.  Low‐risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients , 2010, International journal of cancer.

[3]  Hoda Anton-Culver,et al.  Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  A. Børresen-Dale,et al.  Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study , 2010, Human mutation.

[5]  C. Berg,et al.  Second solid cancers after radiotherapy for breast cancer in SEER cancer registries , 2009, British Journal of Cancer.

[6]  N. Miller,et al.  Low penetrance breast cancer predisposition SNPs are site specific , 2009, Breast Cancer Research and Treatment.

[7]  M. Beckmann,et al.  Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. , 2009, Journal of the National Cancer Institute.

[8]  Giske Ursin,et al.  FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. , 2009, Human molecular genetics.

[9]  W. Willett,et al.  A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1) , 2009, Nature Genetics.

[10]  M. Thun,et al.  Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 , 2009, Nature Genetics.

[11]  D. Eccles,et al.  The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer , 2008, Breast Cancer Research.

[12]  Hongbing Shen,et al.  Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. , 2008, Carcinogenesis.

[13]  J. Boice,et al.  Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. , 2008, International journal of radiation oncology, biology, physics.

[14]  J. Struewing,et al.  Breast Cancer Risk Polymorphisms and Interaction with Ionizing Radiation among U.S. Radiologic Technologists , 2008, Cancer Epidemiology Biomarkers & Prevention.

[15]  A. Sigurdsson,et al.  Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer , 2008, Nature Genetics.

[16]  B. Ponder,et al.  Allele-Specific Up-Regulation of FGFR2 Increases Susceptibility to Breast Cancer , 2008, PLoS biology.

[17]  Dieter Niederacher,et al.  Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. , 2008, American journal of human genetics.

[18]  Peter Kraft,et al.  Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics , 2008, PLoS genetics.

[19]  P. Gregersen,et al.  Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33 , 2008, Proceedings of the National Academy of Sciences.

[20]  R. Supramaniam.  New malignancies among cancer survivors: SEER cancer registries, 1973–2000 , 2008, Journal of Epidemiology & Community Health.

[21]  Julian Peto,et al.  Association of Genetic Variants at 8q24 with Breast Cancer Risk , 2008, Cancer Epidemiology Biomarkers & Prevention.

[22]  C. Begg,et al.  Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study. , 2008, Journal of the National Cancer Institute.

[23]  J. Klijn,et al.  Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases , 2007, Breast Cancer Research.

[24]  D. Gudbjartsson,et al.  Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer , 2007, Nature Genetics.

[25]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[26]  T. Zacharewski,et al.  Comparative temporal and dose-dependent morphological and transcriptional uterine effects elicited by tamoxifen and ethynylestradiol in immature, ovariectomized mice , 2007, BMC Genomics.

[27]  W. Willett,et al.  A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.

[28]  Yi Zhang,et al.  Genes associated with breast cancer metastatic to bone. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  Xiaoli Shen,et al.  PTH-related protein enhances MCF-7 breast cancer cell adhesion, migration, and invasion via an intracrine pathway. , 2004, Experimental cell research.

[30]  Bryan Langholz,et al.  Study design: Evaluating gene–environment interactions in the etiology of breast cancer – the WECARE study , 2004, Breast Cancer Research.

[31]  P. Porter,et al.  Epidemiologic and molecular risk factors for contralateral breast cancer among young women , 2003, British Journal of Cancer.

[32]  R. J. Thomas,et al.  Parathyroid hormone-related protein (PTHrP)-(1-139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo. , 2002, Bone.

[33]  N. Risch,et al.  Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. , 1992, American journal of epidemiology.

[34]  A. Børresen-Dale,et al.  Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. , 2010, Journal of the National Cancer Institute.

[35]  R. Hoover,et al.  New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. , 2006 .